Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

293 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Erratum. A Randomized Controlled Trial Comparing Efficacy and Safety of Insulin Glargine 300 Units/mL Versus 100 Units/mL in Older People With Type 2 Diabetes: Results From the SENIOR Study. Diabetes Care 2018;41:1672-1680.
Ritzel R, Harris SB, Baron H, Florez H, Roussel R, Espinasse M, Muehlen-Bartmer I, Zhang N, Bertolini M, Brulle-Wohlhueter C, Munshi M, Bolli GB. Ritzel R, et al. Among authors: roussel r. Diabetes Care. 2019 Aug;42(8):1604. doi: 10.2337/dc19-er08. Epub 2019 Jun 21. Diabetes Care. 2019. PMID: 31227584 Free PMC article. No abstract available.
A Randomized Controlled Trial Comparing Efficacy and Safety of Insulin Glargine 300 Units/mL Versus 100 Units/mL in Older People With Type 2 Diabetes: Results From the SENIOR Study.
Ritzel R, Harris SB, Baron H, Florez H, Roussel R, Espinasse M, Muehlen-Bartmer I, Zhang N, Bertolini M, Brulle-Wohlhueter C, Munshi M, Bolli GB. Ritzel R, et al. Among authors: roussel r. Diabetes Care. 2018 Aug;41(8):1672-1680. doi: 10.2337/dc18-0168. Epub 2018 Jun 12. Diabetes Care. 2018. PMID: 29895556 Clinical Trial.
More Similarities Than Differences Testing Insulin Glargine 300 Units/mL Versus Insulin Degludec 100 Units/mL in Insulin-Naive Type 2 Diabetes: The Randomized Head-to-Head BRIGHT Trial.
Rosenstock J, Cheng A, Ritzel R, Bosnyak Z, Devisme C, Cali AMG, Sieber J, Stella P, Wang X, Frías JP, Roussel R, Bolli GB. Rosenstock J, et al. Among authors: roussel r. Diabetes Care. 2018 Oct;41(10):2147-2154. doi: 10.2337/dc18-0559. Epub 2018 Aug 13. Diabetes Care. 2018. PMID: 30104294 Clinical Trial.
Better glycaemic control and less hypoglycaemia with insulin glargine 300 U/mL vs glargine 100 U/mL: 1-year patient-level meta-analysis of the EDITION clinical studies in people with type 2 diabetes.
Ritzel R, Roussel R, Giaccari A, Vora J, Brulle-Wohlhueter C, Yki-Järvinen H. Ritzel R, et al. Among authors: roussel r. Diabetes Obes Metab. 2018 Mar;20(3):541-548. doi: 10.1111/dom.13105. Epub 2017 Oct 5. Diabetes Obes Metab. 2018. PMID: 28862801 Free PMC article. Review.
Plasma Copeptin and Risk of Lower-Extremity Amputation in Type 1 and Type 2 Diabetes.
Potier L, Roussel R, Marre M, Bjornstad P, Cherney DZ, El Boustany R, Fumeron F, Venteclef N, Gautier JF, Hadjadj S, Mohammedi K, Velho G. Potier L, et al. Among authors: roussel r. Diabetes Care. 2019 Dec;42(12):2290-2297. doi: 10.2337/dc19-1062. Epub 2019 Oct 3. Diabetes Care. 2019. PMID: 31582427 Free PMC article.
Dynamic Changes in Renal Function Are Associated With Major Cardiovascular Events in Patients With Type 2 Diabetes.
Ragot S, Saulnier PJ, Velho G, Gand E, de Hauteclocque A, Slaoui Y, Potier L, Sosner P, Halimi JM, Zaoui P, Rigalleau V, Fumeron F, Roussel R, Marre M, Hadjadj S; SURDIAGENE and DIABHYCAR study groups. Ragot S, et al. Among authors: roussel r. Diabetes Care. 2016 Jul;39(7):1259-66. doi: 10.2337/dc15-2607. Epub 2016 May 23. Diabetes Care. 2016. PMID: 27222502
293 results